Zein Biotechnology Co., Ltd.
As of 18 November 2026, for the company name Zein Biotechnology Co., Ltd. as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 35 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
31 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
琥珀酸地文拉法辛缓释片 · No verified English name 2 records · Latest accepted 2026/08/25
Generic · 2
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2026/08/13
Generic · 2
Ropinirole Hydrochloride Sustained-release Tablets 3 records · Latest accepted 2026/03/26
Supplement · 1Generic · 2
Edoxaban Tosilate Tablets 3 records · Latest accepted 2026/02/06
Generic · 3
Fexofenadine Hydrochloride Tablets 4 records · Latest accepted 2025/08/21
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503071 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| CYHS2503070 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| CYHS2503069 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| CYHS2503068 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
Voriconazole Tablets 2 records · Latest accepted 2025/07/17
Generic · 2
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2024/03/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400901 | Generic | 2024/03/23 | Zein Biotechnology Co., Ltd. | CDE ↗ |
Pramipexole Dihydrochloride Tablets 2 records · Latest accepted 2024/01/09
Generic · 2
Pramipexole Dihydrochloride Prolonged-release Tablets 2 records · Latest accepted 2023/10/25
Generic · 2
Flupentixol and Melitracen Tablets 2 records · Latest accepted 2023/08/23
Generic · 2
Sildenafil Citrate Tablets 3 records · Latest accepted 2023/05/24
Generic · 3
Tadalafil Tablets 1 records · Latest accepted 2023/03/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300617 | Supplement | 2023/03/25 | Zein Biotechnology Co., Ltd. | CDE ↗ |
Orlistat Capsules 2 records · Latest accepted 2022/02/17
Supplement · 2
Rivaroxaban Tablets 1 records · Latest accepted 2022/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200270 | Generic | 2022/02/08 | Zein Biotechnology Co., Ltd. | CDE ↗ |
阿柏西普眼内注射溶液 · No verified English name 1 records · Latest accepted 2022/01/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200003 | New drug | 2022/01/05 | Zein Biotechnology Co., Ltd. | CDE ↗ |
Changes in the last 90 days
5 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 2 applicationsAccepted: 2 applicationsNotification delivery: 1 application
- 2026/11/03Marketing application approved
Voriconazole Tablets
CYHS2502561 · 国药准字H20266476
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 97 ↗ - 2026/11/03Marketing application approved
Voriconazole Tablets
CYHS2502560 · 国药准字H20266475
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 96 ↗ - 2026/10/28Notification delivery
Dapoxetine Hydrochloride Tablets
CYHS2602001
Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 23 ↗ - 2026/08/25Accepted
琥珀酸地文拉法辛缓释片 · No verified English name
CYHS2602120
Fact date: 2026/08/25 · Date added to this site: 2026/10/22
View source ↗ - 2026/08/25Accepted
琥珀酸地文拉法辛缓释片 · No verified English name
CYHS2602119
Fact date: 2026/08/25 · Date added to this site: 2026/10/22
View source ↗
Under review
10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 琥珀酸地文拉法辛缓释片 · No verified English name | CYHS2602120 | Generic | 2026/08/25 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | CYHS2602119 | Generic | 2026/08/25 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Ropinirole Hydrochloride Sustained-release Tablets | CYHB2600595 | Supplement | 2026/03/26 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2600395 | Generic | 2026/02/06 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2600394 | Generic | 2026/02/06 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Edoxaban Tosilate Tablets | CYHS2600393 | Generic | 2026/02/06 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2503071 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2503070 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2503069 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2503068 | Generic | 2025/08/21 | Zein Biotechnology Co., Ltd. | CDE ↗ |
Catalogue holder records
17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Pramipexole Dihydrochloride Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20254232 | 2025/05/20 | Not stated by source | CDE ↗ |
| Pramipexole Dihydrochloride Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20254233 | 2025/05/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ropinirole Hydrochloride Sustained-release Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20253817 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20253686 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20253687 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20253123 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Flupentixol and Melitracen Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20249160 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20244695 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20244696 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20244697 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20247084 | 2024/04/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20234143 | 2023/09/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Orlistat Capsules | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20133171 | 2023/05/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Orlistat Capsules | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20123131 | 2023/05/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tadalafil Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20223101 | 2022/03/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ropinirole Hydrochloride Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20130045 | 2022/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropinirole Hydrochloride Tablets | Zein Biotechnology Co., Ltd. | Zein Biotechnology Co., Ltd. | 国药准字H20130044 | 2022/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
35 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 伏格列波糖 · No verified English name | Zein Biotechnology Co., Ltd. | Y20260000626 | I | 2026/08/07 | CDE ↗ |
| 亚甲蓝 · No verified English name | Zein Biotechnology Co., Ltd. | Y20260000570 | I | 2026/07/31 | CDE ↗ |
| 伊班膦酸钠 · No verified English name | Zein Biotechnology Co., Ltd. | Y20260000393 | I | 2026/06/04 | CDE ↗ |
| 盐酸氯普鲁卡因 · No verified English name | Zein Biotechnology Co., Ltd. | Y20260000278 | I | 2026/05/12 | CDE ↗ |
| 马来酸左氨氯地平 · No verified English name | Zein Biotechnology Co., Ltd. | Y20250001196 | I | 2025/12/02 | CDE ↗ |
| 重酒石酸去甲肾上腺素 · No verified English name | Zein Biotechnology Co., Ltd. | Y20250001057 | I | 2025/10/15 | CDE ↗ |
| 盐酸齐拉西酮 · No verified English name | Zein Biotechnology Co., Ltd. | Y20250000981 | I | 2025/09/11 | CDE ↗ |
| 盐酸乙哌立松 · No verified English name | Zein Biotechnology Co., Ltd. | Y20250000383 | A | 2026/11/13 | CDE ↗ |
| 盐酸曲唑酮 · No verified English name | Zein Biotechnology Co., Ltd. | Y20250000281 | I | 2025/03/26 | CDE ↗ |
| 布立西坦 · No verified English name | Zein Biotechnology Co., Ltd. | Y20240001550 | I | 2025/01/13 | CDE ↗ |
| 无水乙醇 · No verified English name | Zein Biotechnology Co., Ltd. | Y20240001251 | A | 2026/04/29 | CDE ↗ |
| 伏立康唑 · No verified English name | Zein Biotechnology Co., Ltd. | Y20240000547 | A | 2025/11/14 | CDE ↗ |
| 富马酸单甲酯 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230001093 | I | 2024/03/11 | CDE ↗ |
| 帕拉米韦 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230001127 | A | 2026/08/22 | CDE ↗ |
| 甲苯磺酸艾多沙班 · No verified English name | Zein Biotechnology Co., Ltd. | Y20240000002 | A | 2025/05/28 | CDE ↗ |
| 盐酸美利曲辛 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000670 | A | 2026/02/14 | CDE ↗ |
| 达格列净 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000618 | A | 2026/06/04 | CDE ↗ |
| 琥珀酸地文拉法辛 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000468 | A | 2026/07/25 | CDE ↗ |
| 盐酸托莫西汀 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000127 | A | 2024/09/25 | CDE ↗ |
| 拉考沙胺 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000125 | A | 2024/10/25 | CDE ↗ |
| 他达拉非 · No verified English name | Zein Biotechnology Co., Ltd. | Y20230000048 | A | 2025/12/17 | CDE ↗ |
| 硫酸钾 · No verified English name | Zein Biotechnology Co., Ltd. | Y20220001220 | A | 2024/06/05 | CDE ↗ |
| 枸橼酸苯海拉明 · No verified English name | Zein Biotechnology Co., Ltd. | Y20220001232 | A | 2026/02/26 | CDE ↗ |
| 罗格列酮钠 · No verified English name | Zein Biotechnology Co., Ltd. | Y20220001267 | A | 2024/05/22 | CDE ↗ |
| 盐酸依匹斯汀 · No verified English name | Zein Biotechnology Co., Ltd. | Y20220001174 | A | 2024/07/09 | CDE ↗ |
| 盐酸美金刚 · No verified English name | Zein Biotechnology Co., Ltd. | Y20220000214 | A | 2023/12/05 | CDE ↗ |
| 盐酸氟哌噻吨 · No verified English name | Zein Biotechnology Co., Ltd. | Y20210001166 | A | 2023/07/24 | CDE ↗ |
| 利伐沙班 · No verified English name | Zein Biotechnology Co., Ltd. | Y20210001063 | A | 2025/04/16 | CDE ↗ |
| 硫酸特布他林 · No verified English name | Zein Biotechnology Co., Ltd. | Y20210000916 | A | 2026/03/21 | CDE ↗ |
| 盐酸美利曲辛 · No verified English name | Zein Biotechnology Co., Ltd. | Y20210000944 | I | 2023/06/28 | CDE ↗ |
| 盐酸罗匹尼罗 · No verified English name | Zein Biotechnology Co., Ltd. | Y20190007181 | A | — | CDE ↗ |
| 甲磺司特 · No verified English name | Zein Biotechnology Co., Ltd. | Y20190006952 | A | 2024/07/23 | CDE ↗ |
| 盐酸托烷司琼 · No verified English name | Zein Biotechnology Co., Ltd. | Y20190006006 | A | 2025/10/22 | CDE ↗ |
| 盐酸多奈哌齐 · No verified English name | Zein Biotechnology Co., Ltd. | Y20190005502 | A | 2025/07/04 | CDE ↗ |
| 奥利司他 · No verified English name | Zein Biotechnology Co., Ltd. | Y20190002310 | A | 2025/08/16 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
32 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Metformin Hydrochloride Extended-release Tablets | CYHB2601858 | Supplement | 2026/10/10 | Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Acetylcysteine Tablets | CYHS2600860 | Generic | 2026/04/15 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Eperisone Hydrochloride Tablets | CYHS2600582 | Generic | 2026/02/28 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Ziprasidone Hydrochloride Capsules | CYHS2600263 | Generic | 2026/01/23 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Ziprasidone Hydrochloride Capsules | CYHS2600262 | Generic | 2026/01/23 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Acetylcysteine Tablets | CYHS2600151 | Generic | 2026/01/13 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 马来酸左氨氯地平片 · No verified English name | CYHS2504318 | Generic | 2025/12/19 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2503230 | Generic | 2025/09/02 | Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2503229 | Generic | 2025/09/02 | Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2503228 | Generic | 2025/09/02 | Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | CYHS2503145 | Generic | 2025/08/27 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | CYHS2503144 | Generic | 2025/08/27 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Levodopa and Benserazide Hydrochloride Tablets | CYHS2500784 | Generic | 2025/02/18 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| LJ01003 · No verified English name | CXHS2500009 | New drug | 2025/01/21 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| LJ01003 · No verified English name | CXHS2500008 | New drug | 2025/01/21 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Rivaroxaban Tablets | CYHB2402256 | Supplement | 2024/12/31 | Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2403646 | Generic | 2024/10/26 | Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2403645 | Generic | 2024/10/26 | Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 甲磺司特颗粒 · No verified English name | CYHB2450431 | Supplement | 2024/08/13 | Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 甲磺司特颗粒 · No verified English name | CYHB2450430 | Supplement | 2024/08/13 | Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 甲磺司特颗粒 · No verified English name | CYHB2450429 | Supplement | 2024/08/13 | Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 枸橼酸苯海拉明布洛芬片 · No verified English name | CYHS2401813 | Generic | 2024/06/18 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Rivaroxaban Tablets | CYHB2400417 | Supplement | 2024/03/25 | Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Paracetamol and Ibuprofen Tablets | CYHS2303092 | Generic | 2023/11/10 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| 甲磺司特颗粒 · No verified English name | CYHB2301054 | Supplement | 2023/05/13 | Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| LJ01003 · No verified English name | CXHS2300046 | New drug | 2023/04/18 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| LJ01003 · No verified English name | CXHS2300045 | New drug | 2023/04/18 | Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Ropinirole Hydrochloride Tablets | CYHB2300646 | Supplement | 2023/03/30 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Ropinirole Hydrochloride Tablets | CYHB2300645 | Supplement | 2023/03/30 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | CYHB2300644 | Supplement | 2023/03/30 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | CYHB2300643 | Supplement | 2023/03/30 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | CYHB2340008 | Supplement | 2023/02/09 | Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.